Trump Rattled Markets Again and These 3 Forgotten Stocks Under $30 Were the Unlikely Winners

Photo of Alex Sirois
By Alex Sirois Published
Trump Rattled Markets Again and These 3 Forgotten Stocks Under $30 Were the Unlikely Winners

© iip-photo-archive / Flickr

President Trump’s 12-word remark, “I don’t think about Americans’ financial situation, I don’t think about anybody,” hit the wires, and the reaction showed up in the forgotten corners of the market, where micro-cap turnarounds priced like option contracts ripped higher on May 15 as traders rotated into beaten-down names with operational catalysts already in motion. When the headline tape gets emotional, sub-$30 stocks with a real story attached tend to move first and hardest.

With that in mind, here are three stocks trading under $30 that surged on May 15, 2026, and where the underlying fundamentals support the move rather than just the headline.

P3 Health Partners (NASDAQ: PIII)

P3 Health Partners (NASDAQ:PIII) is a value-based care operator serving Medicare Advantage populations. Shares closed at $11.29 on May 15, up roughly 180% on the day on volume of 64.2 million shares. For a retail investor, that is a name that just announced itself.

The Q1 2026 report filed May 14, 2026 showed EPS of $0.32 versus a consensus of -$3.50, revenue of $386.39 million (+3.5% YoY), and a swing to GAAP net income of $3.04 million from a $44.25 million loss. Medical margin expanded to $73.66 million from $17.20 million, and management raised FY2026 adjusted EBITDA guidance to a $40 million midpoint. CEO Aric Coffman called the quarter “a meaningful turning point for the business.”

The bull case is straightforward: dramatic margin expansion, raised guidance, and a $252.5 million debt-to-preferred-equity conversion that resolves the NASDAQ compliance overhang. The risk that cuts the other way is real, including going concern doubt and negative stockholders’ equity of $143.5 million, plus an analyst target price of $3.50 that sits well below where shares closed. PIII is a high-conviction operational rerate that still has to prove its balance sheet.

Trio-Tech International (NYSE: TRT)

Trio-Tech International (NYSE:TRT) provides reliability testing services for semiconductor customers, with growing exposure to AI and EV chips. Shares closed at $20.05, up 43% on the session, putting the stock at the high end of its 52-week range of $2.31 to $21.38.

Fiscal Q3 2026 revenue hit $16.51 million, +123.6% YoY, with the Semiconductor Back-End Solutions segment up 141%. Trio-Tech also booked $7.8 million in cumulative Burn-In Board orders for a next-generation AI GPU platform and signed a lease on a 104,000 square foot facility in Penang, Malaysia. Market cap stands at $202.8 million.

The bull case is direct exposure to AI testing capacity at a triple-digit growth rate. The bear case is gross margin compression to 16% from 27%, the $10 million registered direct equity offering completed post-quarter, and trade-tension risk on Asia revenue. The trajectory looks like a small-cap AI infrastructure proxy with execution risk attached.

Super League Enterprise (NASDAQ: SLE)

Super League Enterprise (NASDAQ:SLE) sells in-game advertising on Roblox, Fortnite, Minecraft, and mobile. Shares closed at $6.04, up 48% on the day on 45.6 million shares. The market cap is tiny at roughly $9 million, which is why these moves get violent.

Q4 2025 EPS came in at -$0.96 versus a -$2.88 consensus, and the company ended 2025 debt-free with $14.39 million in cash, against $1.31 million the prior year. Management is guiding to cash-basis EBITDA profitability by year-end 2026 and gross margins toward 45%. CEO Matt Edelman said “Super League is a fundamentally different company than it was a year ago.” Wall Street’s target sits at $14.50.

Bull case: a debt-free, cash-funded turnaround with a pending Misfits Ads Division acquisition that represents roughly 50% of 2025 standalone revenue. Bear case: full-year 2025 revenue still declined 30%, the float is microscopic, and the acquisition needs stockholder approval. The setup rewards patience and conviction.

Do your own research, size positions accordingly, and treat single-day surges as a starting point for diligence rather than the conclusion of it.

Photo of Alex Sirois
About the Author Alex Sirois →

Alex Sirois is a financial writer with experience spanning both retail and institutional investing. He has written for InvestorPlace and held roles at BNY Mellon and Bernstein, giving him a perspective that bridges Main Street portfolios and Wall Street analysis.

Alex holds an MBA from George Washington University and has built his career across multiple industries, including e-commerce, education, and translation — a breadth of experience that informs how he breaks down complex financial topics for everyday investors. His writing is conversational, actionable, and grounded in long-term, buy-and-hold investing principles.

At 247 Wall St., Alex focuses on delivering analysis that is both accessible and useful, with a clear emphasis on helping readers make more informed decisions with their money.

Continue Reading

Top Gaining Stocks

COO Vol: 9,090,870
CLX Vol: 3,290,263
KVUE Vol: 24,618,710
KMB Vol: 6,361,016
ALL Vol: 1,638,476

Top Losing Stocks

ENPH Vol: 10,448,766
MU Vol: 77,252,156
TER Vol: 5,480,426
FSLR Vol: 3,903,927
INTC Vol: 145,138,050